Tags

Type your tag names separated by a space and hit enter

SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland.
Viruses. 2021 06 22; 13(7)V

Abstract

As pregnant women are at high risk of severe SARS-CoV-2 infection and COVID-19 vaccines are available in Switzerland, this study aimed to assess the willingness of Swiss pregnant and breastfeeding women to become vaccinated. Through a cross-sectional online study conducted after the first pandemic wave, vaccination practices and willingness to become vaccinated against SARS-CoV-2 if a vaccine was available were evaluated through binary, multi-choice, and open-ended questions. Factors associated with vaccine willingness were evaluated through univariable and multivariable analysis. A total of 1551 women responded to questions related to the primary outcome. Only 29.7% (153/515) of pregnant and 38.6% (400/1036) of breastfeeding women were willing to get vaccinated against SARS-CoV-2 if a vaccine had been available during the first wave. Positive predictors associated with SARS-CoV-2 vaccine acceptance were an age older than 40 years, a higher educational level, history of influenza vaccination within the previous year, having an obstetrician as the primary healthcare practitioner, and being in their third trimester of pregnancy. After the first pandemic wave, Switzerland had a low SARS-CoV-2 vaccination acceptance rate, emphasizing the need to identify and reduce barriers for immunization in pregnant and breastfeeding women, particularly among the youngest and those with a lower educational level.

Authors+Show Affiliations

Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium. Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH 's-Hertogenbosch, The Netherlands.Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0315 Oslo, Norway. Department of Child Health and Development, Norwegian Institute of Public Health, 0403 Oslo, Norway.Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland. Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland. School of Health Sciences (HESAV) Midwifery Department, University of Applied Sciences and Arts Western Switzerland, 1011 Lausanne, Switzerland.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34206645

Citation

Stuckelberger, Sarah, et al. "SARS-CoV-2 Vaccine Willingness Among Pregnant and Breastfeeding Women During the First Pandemic Wave: a Cross-Sectional Study in Switzerland." Viruses, vol. 13, no. 7, 2021.
Stuckelberger S, Favre G, Ceulemans M, et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses. 2021;13(7).
Stuckelberger, S., Favre, G., Ceulemans, M., Nordeng, H., Gerbier, E., Lambelet, V., Stojanov, M., Winterfeld, U., Baud, D., Panchaud, A., & Pomar, L. (2021). SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses, 13(7). https://doi.org/10.3390/v13071199
Stuckelberger S, et al. SARS-CoV-2 Vaccine Willingness Among Pregnant and Breastfeeding Women During the First Pandemic Wave: a Cross-Sectional Study in Switzerland. Viruses. 2021 06 22;13(7) PubMed PMID: 34206645.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. AU - Stuckelberger,Sarah, AU - Favre,Guillaume, AU - Ceulemans,Michael, AU - Nordeng,Hedvig, AU - Gerbier,Eva, AU - Lambelet,Valentine, AU - Stojanov,Milos, AU - Winterfeld,Ursula, AU - Baud,David, AU - Panchaud,Alice, AU - Pomar,Léo, Y1 - 2021/06/22/ PY - 2021/05/31/received PY - 2021/06/15/revised PY - 2021/06/18/accepted PY - 2021/7/2/entrez PY - 2021/7/3/pubmed PY - 2021/7/16/medline KW - COVID-19 KW - SARS-CoV-2 KW - breastfeeding KW - coronavirus KW - pregnancy KW - vaccine willingness JF - Viruses JO - Viruses VL - 13 IS - 7 N2 - As pregnant women are at high risk of severe SARS-CoV-2 infection and COVID-19 vaccines are available in Switzerland, this study aimed to assess the willingness of Swiss pregnant and breastfeeding women to become vaccinated. Through a cross-sectional online study conducted after the first pandemic wave, vaccination practices and willingness to become vaccinated against SARS-CoV-2 if a vaccine was available were evaluated through binary, multi-choice, and open-ended questions. Factors associated with vaccine willingness were evaluated through univariable and multivariable analysis. A total of 1551 women responded to questions related to the primary outcome. Only 29.7% (153/515) of pregnant and 38.6% (400/1036) of breastfeeding women were willing to get vaccinated against SARS-CoV-2 if a vaccine had been available during the first wave. Positive predictors associated with SARS-CoV-2 vaccine acceptance were an age older than 40 years, a higher educational level, history of influenza vaccination within the previous year, having an obstetrician as the primary healthcare practitioner, and being in their third trimester of pregnancy. After the first pandemic wave, Switzerland had a low SARS-CoV-2 vaccination acceptance rate, emphasizing the need to identify and reduce barriers for immunization in pregnant and breastfeeding women, particularly among the youngest and those with a lower educational level. SN - 1999-4915 UR - https://www.unboundmedicine.com/medline/citation/34206645/SARS_CoV_2_Vaccine_Willingness_among_Pregnant_and_Breastfeeding_Women_during_the_First_Pandemic_Wave:_A_Cross_Sectional_Study_in_Switzerland_ L2 - https://www.mdpi.com/resolver?pii=v13071199 DB - PRIME DP - Unbound Medicine ER -